Skip to main content

Artis Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

63
Companies
$2.2B
Total invested
$35.5M
Avg. check
48
Industries
Health Care 12Biotechnology 11Life Science 8Artificial Intelligence (AI) 7Medical 6Therapeutics 5+42 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 63
GenHealth.ai
September 2026

GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events.

Artificial Intelligence (AI) · Vienna$16.5M Series A
Network Bio
August 2026

Network Bio develops AI platforms designed to learn from human biology and support medical research and healthcare applications.

Artificial Intelligence (AI) · New York$50.0M Venture - Series Unknown
Valarian Technologies
July 2026

Valarian develops infrastructure and software for managing sensitive data, communications, and AI workloads in secure environments.

Artificial Intelligence (AI) · London$50.0M Series A
Arkenstone Defense
July 2026

Arkenstone Defense is a compliance and operations software platform for defense contractors.

GovTech · Menlo Park$35.0M Seed
Conceivable Life Sciences
July 2026

Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.

Artificial Intelligence (AI) · New York$18.0M Corporate Round
Siren Biotechnology
June 2026

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

Biotechnology · San Francisco$8.0M Grant
Onto Health
April 2026

Onto Health offers tech-enabled fertility care, including IVF, egg freezing, IUI, and digital tools for personalized reproductive support.

Fertility · Parker$20.0M Series A
Tessera Therapeutics
March 2026

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Biopharma · CambridgeGrant
Unnatural Products
March 2026

Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.

Artificial Intelligence (AI) · Santa Cruz$45.0M Series B
Science
March 2026

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Biotechnology · Alameda$230.0M Series C
Bettani
October 2025

Bettani creates plant-based ingredients and products using data-driven technology and culinary expertise.

Biotechnology · Berkeley$6.5M Series A
Glyphic Biotechnologies
September 2025

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

Biotechnology · New York$38.0M Series A
Delix Therapeutics
September 2025

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Biotechnology · Boston$25.0M Series B
Rad AI
May 2025

Rad AI develops software that uses AI to automate radiology report writing, aiming to enhance accuracy and reduce radiologist burnout.

Artificial Intelligence (AI) · San Francisco$8.0M Series C
Delfina
January 2025

Delfina provides a personalized prenatal care system that uses the power of data to keep moms and babies safe during pregnancy.

Health Care · San Francisco$17.0M Series A
Ozlo Sleep
October 2024

Ozlo Sleep is a science-driven sleep and audio technology company that simplifies sleep rituals without the use of medication.

Consumer Electronics · Northborough$12.0M Venture - Series Unknown
Outpace Bio
August 2024

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Biotechnology · Seattle$144.0M Series B
Eko Health
June 2024

Eko Health is a digital health company providing digital stethoscopes and an AI detection platform for diagnosing heart and lung diseases.

Artificial Intelligence (AI) · Emeryville$41.0M Series D
Enklu
January 2024

The spatial marketplace powering the only location-based AR network connecting players and developers in 5 countries and 22 markets.

Augmented Reality · Chicago$1.3M Seed
Athena Club
January 2024

Athena Club is an omnichannel subscription-based company that provides personal care products for women.

Consumer · New York$33.5M Venture - Series Unknown
Power Life Science
December 2023

Power Life Science is a patient-friendly platform that provides access to clinical trials by condition, location, and drug type.

Clinical Trials · San Francisco$11.9M Series A
Meomind
November 2023

Mental health benefit for employers and payers.

Health Care · San FranciscoSeed
Affect
September 2025

Affect uses mobile technology to revolutionize stimulant addiction recovery.

Addiction Treatment · New York$26.0M Series B
OverT Bio
November 2024

OverT Bio operates as a biotech company that provide cell therapy for cancers.

Biotechnology · New York$120K Grant

Where Artis Ventures invests

Health Care12
Biotechnology11
Life Science8
Artificial Intelligence (AI)7
Medical6
Therapeutics5

About Artis Ventures's portfolio

How many companies has Artis Ventures invested in?▸

Artis Ventures has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Artis Ventures invest in?▸

Artis Ventures's top investment sectors include Health Care, Biotechnology, Life Science, Artificial Intelligence (AI), Medical. The firm invests across 48 different industry categories.

What is Artis Ventures's largest investment?▸

Among tracked funding rounds, Science received $230.0M in a Series C round. Artis Ventures's total known invested capital is $2.2B.

What is the average investment size for Artis Ventures?▸

Artis Ventures's average investment size is $35.5M across its portfolio of 63 companies.

What are Artis Ventures's most recent investments?▸

Recent Artis Ventures portfolio additions include GenHealth.ai, Network Bio, Valarian Technologies, Arkenstone Defense, Conceivable Life Sciences. These companies were founded in 2020 or later.

Reach the founders behind these 63 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →